Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE

PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM

Standard Dose
200MG,N/A,N/A;N/A,800MG,160MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 021105 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM Form and strength TABLET;ORAL - 200MG,N/A,N/A;N/A,800MG,160MG Sponsor ABLE Submission history Latest submission status date: 2001-06-26 00:00:00.

Structured Monograph

Clinical summary

Approval overview SULFAMETHOXAZOLE AND TRIMETHOPRIM AND PHENAZOPYRIDINE HYDROCHLORIDE is listed in Drugs@FDA under application 021105 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PHENAZOPYRIDINE HYDROCHLORIDE; SULFAMETHOXAZOLE; TRIMETHOPRIM Form and strength TABLET;ORAL - 200MG,N/A,N/A;N/A,800MG,160MG Sponsor ABLE Submission history Latest submission status date: 2001-06-26 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.